Aging and PMN response to P. aeruginosa infection

K A Kernacki1, R P Barrett, S A McClellan

  • 1Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

Abstract

Insights

Aging impairs polymorphonuclear neutrophil (PMN) function, leading to delayed bacterial clearance and increased corneal damage after Pseudomonas aeruginosa infection. Macrophage inflammatory protein-2 (MIP-2) neutralization mitigates these aging-related immune deficits.

Area of Science:

  • Immunology
  • Ophthalmology
  • Microbiology

Background:

  • Aging is linked to immune system dysfunction, potentially increasing disease severity in older individuals.
  • Polymorphonuclear neutrophils (PMNs) are critical immune cells involved in combating bacterial infections, including those affecting the cornea.

Purpose of the Study:

  • To investigate aging-related alterations in PMN function following corneal infection with Pseudomonas aeruginosa.
  • To determine the role of macrophage inflammatory protein-2 (MIP-2) in the aged immune response to P. aeruginosa keratitis.

Main Methods:

  • Comparison of PMN number, MIP-2 expression (mRNA and protein), and bacterial load in young (8-week) and aged (12-month) BALB/c mice post-P. aeruginosa infection.
  • Systemic administration of MIP-2 neutralizing antibody in aged mice to assess its impact on ocular disease and PMN recruitment.

Main Results:

  • Aged mice exhibited delayed PMN infiltration and impaired bacterial load reduction in the cornea.
  • Increased PMN numbers in aged corneas correlated with persistent MIP-2 expression.
  • MIP-2 neutralization in aged mice reduced corneal PMN infiltration and attenuated ocular disease severity.

Conclusions:

  • Persistent PMN presence in the cornea of aged mice contributes to tissue destruction after P. aeruginosa challenge.
  • The chemoattractant MIP-2 plays a significant role in the altered PMN response observed in aged individuals during P. aeruginosa keratitis.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...